Instrumentarium Corp.
This article was originally published in The Gray Sheet
Executive Summary
Helsinki, Finland-based company reaches a basic agreement with Swedish firm Gambro AB under which Instrumentarium will acquire Gambro's anaesthesia and intensive care business. The business being acquired is comprised of the Gambro Engstrom AB, Engstrom Elektromedizin GmbH, Soxil SpA, and Engstrom MIE Ltd. divisions, based in Sweden, Germany, Italy, and the U.K., respectively. The four businesses had combined 1993 sales of approximately $58 mil., according to Instrumentarium. Instrumentarium says the acquisition will "particularly strengthen" its Datex division in the areas of anaesthesia and critical care equipment, where there is "a strong trend towards integration of patient monitoring, anaesthesia delivery and information management." Datex posted 1993 sales of about $100 mil
You may also be interested in...
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.